Nicotinamide Mononucleotide (NMN): Difference between revisions

Nicotinamide Mononucleotide (NMN) (view source)

609 bytes added , 16 November 2023

2,851

edits

@@ Line 121: / Line 121: @@
 |[[File:NMN NAD+ Human.png|frameless]]
 |
+* '''Safety''': basically safe under the existing intervention dose and time^35,36,118,122,140,141,145-147,178
+* '''Sleep quality''': no significant improvement^35,118
+* '''Physical activity''': prevented aging-related muscle dysfunctions and improving physical performance^118,141,145,146
+* '''Eye''': no significant improvement^35
+* '''Ear''': improved the right auditory ability of old men^141
+* '''Cognition''': no significant improvement^141
+* '''Diabetes''': increased muscle insulin sensitivity, insulin signaling, and remodeling in prediabetic women^36
+* '''Telomere''': increased telomere length^147
 |}